Memphis facility to make gene-editing treatment for sickle cell

By , Daily Memphian Published: January 14, 2024 4:00 AM CT

Boston-based Charles River Laboratories manufactures clinical and commercial cell and gene-modified cell therapies at its Shelby Drive facility. 


Sickle Cell Disease Charles River Laboratories biotech
Aisling Mäki

Aisling Mäki

Aisling Mäki has spent the better part of two decades writing about Memphis. A former digital journalist for WMC Action News 5 and staff reporter for Memphis Daily News, her work has also appeared in The Commercial Appeal, High Ground News, I Love Memphis, Inside Memphis Business, The Memphis Flyer, Memphis Parent, Memphis Magazine and Tri-State Defender. 


Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here